WithdrawnPhase 1NCT06173817

The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients

Studying Methanol poisoning

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Oslo University Hospital
Principal Investigator: Knut Erik Hovda, MD, Ph D
The Norwegian CBRNE Centre, Department of Acute Medicine, Oslo University Hospital Oslo, Norway
Intervention: isocapnic hyperventilation(device)
Eligibility: 18-80 years · All sexes
Timeline: 2026 – 2026

Study locations (1)

Loghman-Hakim Hospital,, Tehran, Iran

Collaborators

Loghman-Hakim Hospital, Teheran, Iran · Shohada-e-Tajrish Hospital, Teheran, Iran · Baharloo Hospital, Teheran, Iran · Imam Reza Hospital, Mashhad University of Medical Sciences, Iran · Khorshid Hospital, Isfahan University of Medical Sciences, Iran

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06173817 on ClinicalTrials.gov

Other trials for Methanol poisoning

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06881641
A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning
University of Edinburgh

See all trials for Methanol poisoning →

← Back to all trials